Our team is focused on just a handful of events each year – our Cell & Gene Therapy World and Immuno-Oncology Frontiers (Miami, January); Cell & Gene Therapy Europe and Immuno-Oncology Frontiers (Berlin, September); and our Big Data in Precision Medicine (Washington, DC, October). This level of specialisation means that we have closer links with, and spend more time listening to, the industry we serve than any other conference organiser, aided by the input of our Advisory Boards.
Before a Phacilitate programme is written, we spend at least six weeks conducting intensive market research with potential delegates, sponsors and exhibitors. On the basis of the results of this research, we then work closely with our Advisory Boards to devise agendas that as closely as possible meet all the learning needs of senior industry executives. And we are also listening hard to all types of attendee in order to be able to constantly improve the format of our events. This runs right from agenda structures, which we are constantly seeking to make more and more interactive, through to our online partnering system.